Acorda Therapeutics Shares Indicated Up 8.8% Premarket Fri. Following Renewed Takeover Chatter; Thurs. Stock Rallied As Much As ~7%, Only to Sell Off During Afternoon Session; Report Fri. Morning Suggests Biogen, UCB Are Interested
Paul Quintaro